Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan

Female participants had a higher incidence of headache, nausea, myalgia, arthralgia, redness, pruritus, and inoculation site redness and pruritus (p 0.05). Low grade fever, headache, malaise, myalgia, and inoculation site induration and heat were associated with age group (p 0.05).

Detalles Bibliográficos
Autores principales: Nishizawa, Toshinori, Jinta, Torahiko, Koyamada, Ryosuke, Uehara, Yuki, Taki, Fumika, Arioka, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110989/
https://www.ncbi.nlm.nih.gov/pubmed/35600909
http://dx.doi.org/10.1002/jgf2.545
_version_ 1784709225615720448
author Nishizawa, Toshinori
Jinta, Torahiko
Koyamada, Ryosuke
Uehara, Yuki
Taki, Fumika
Arioka, Hiroko
author_facet Nishizawa, Toshinori
Jinta, Torahiko
Koyamada, Ryosuke
Uehara, Yuki
Taki, Fumika
Arioka, Hiroko
author_sort Nishizawa, Toshinori
collection PubMed
description Female participants had a higher incidence of headache, nausea, myalgia, arthralgia, redness, pruritus, and inoculation site redness and pruritus (p 0.05). Low grade fever, headache, malaise, myalgia, and inoculation site induration and heat were associated with age group (p 0.05).
format Online
Article
Text
id pubmed-9110989
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91109892022-05-17 Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan Nishizawa, Toshinori Jinta, Torahiko Koyamada, Ryosuke Uehara, Yuki Taki, Fumika Arioka, Hiroko J Gen Fam Med Letter to the Editor Female participants had a higher incidence of headache, nausea, myalgia, arthralgia, redness, pruritus, and inoculation site redness and pruritus (p 0.05). Low grade fever, headache, malaise, myalgia, and inoculation site induration and heat were associated with age group (p 0.05). John Wiley and Sons Inc. 2022-04-06 /pmc/articles/PMC9110989/ /pubmed/35600909 http://dx.doi.org/10.1002/jgf2.545 Text en © 2022 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Nishizawa, Toshinori
Jinta, Torahiko
Koyamada, Ryosuke
Uehara, Yuki
Taki, Fumika
Arioka, Hiroko
Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
title Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
title_full Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
title_fullStr Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
title_full_unstemmed Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
title_short Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
title_sort adverse reactions of bnt162b2 vaccine booster against covid‐19 in japan
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110989/
https://www.ncbi.nlm.nih.gov/pubmed/35600909
http://dx.doi.org/10.1002/jgf2.545
work_keys_str_mv AT nishizawatoshinori adversereactionsofbnt162b2vaccineboosteragainstcovid19injapan
AT jintatorahiko adversereactionsofbnt162b2vaccineboosteragainstcovid19injapan
AT koyamadaryosuke adversereactionsofbnt162b2vaccineboosteragainstcovid19injapan
AT ueharayuki adversereactionsofbnt162b2vaccineboosteragainstcovid19injapan
AT takifumika adversereactionsofbnt162b2vaccineboosteragainstcovid19injapan
AT ariokahiroko adversereactionsofbnt162b2vaccineboosteragainstcovid19injapan

Ejemplares similares